Latest News & Features
Americas
Speakers from Akin, Bristol Myers Squibb, Gilead Sciences, and Pfizer discuss how AI accelerates drug discovery, from target identification to predictive modelling, reducing costs and enhancing therapeutic outcomes. 19 December 2024
Americas
Pair of generic drug makers challenged validity of patent on priority, novelty and inventive step | EPO found the patent did not introduce any new matter not originally disclosed in the pharma company’s application. 19 December 2024
Americas
The act’s one-sided provisions and its disproportionate remedies cannot pass constitutional muster, argues John Cox of Barnes & Thornburg. 19 December 2024
Americas
The patent landscape for biologics, biosimilars, and advanced therapeutic antibodies is undergoing rapid change, presenting both opportunities and challenges for innovators and manufacturers. This panel will explore current issues and strategies in this dynamic field. 18 December 2024
Americas
In the world of intellectual property, securing patents for innovative ideas rests heavily on the criteria of novelty, non-obviousness, and the inventive step. 18 December 2024
Americas
LSIPR’s key event series to host its inaugural ceremony next year in Boston | Spotlight on top innovators and firms in life sciences IP | Gala to honour contributions across 21 categories with 15 judges. 17 December 2024
Americas
Regeneron inks deal over suit concerning a protein for testing COVID-19 treatments | BioNTech aims to resolve university dispute over patented tech used in the Comirnaty vaccine. 17 December 2024
Americas
A Delaware jury unanimously sided with Sanofi-owned biotech Inhibrx, clearing it of trade secrets misappropriation claims. Amy Candido of Wilson Sonsini shares insights into the defence strategy that led to the win. 16 December 2024
Americas
Obviousness-type double patenting can pose a significant challenge, as it can lead to unfair extensions of patent rights, and limit other’s abilities to build upon inventions, hindering further innovation. 15 December 2024
Americas
Firm expands its Mechanical & Electromechanical Technologies Practice with latest addition | Partner brings nearly two decades of experience in IP strategy, litigation, and transactions | Experience in biotechnology, medical devices, and blockchain. 12 December 2024